N/A
Completed N=28
Piloting Healthcare Coordination in Hypertension
Source: ClinicalTrials.gov NCT02988193 ↗Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcomePrimary: Clinical Adoption of a Decision Support Artificial Intelligence — 10; 3 Participants
Summary
The PRECISION study investigates the possibility of integrating a clinical decision support analytic intelligence into the clinical care flow at University of California San Francisco Medical Center (UCSF MC). optima-for-blood pressure [optima4BP], our innovation, transforms the episodic and reactive nature of uncontrolled HTN pharmacological treatment management into a process that is continuous, proactive, and personalized.
In addition, the clinical adoption of this "technology of the future" will be investigated to establish its feasibility in being embedded into the clinical care flow.
Today's hypertension (HTN) management paradigm often fails to align current patient health status with the most effective medication treatment. Without surveillance and rapid-cycles analysis of current patient health status and treatment efficacy, HTN management remains a struggle. optima4BP addresses pharmacological intervention management by identifying the need for a drug treatment change and recommending the most appropriate drug optimization.
The PRECISION study represent a pilot trial intended to address 2 critical design components of optima4BP:
1. Can optima4BP interoperate with multiple IT platforms to collect and distribute data?
2. What is the treating physician confidence in using optima4BP?
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Clinical Adoption of a Decision Support Artificial Intelligence |
10; 3 | — |
Eligibility Criteria
Inclusion Criteria
- UCSF General Medicine patient
- 2 or more values on consecutive office visits within 12 months: systolic blood pressure (SBP) > 140 mmHg or diastolic blood pressure (DBP) > 90
- Therapy with at least 2 anti-hypertensive pharmacological classes at the time of the last office visit
Exclusion Criteria
- Does not own a smartphone
- Does not speak or read English
- Planning to leave UCSF in the next year
- Has a treating physician who refuses to enroll patients
- Treating physician states that:
Patient cannot manage Qardio® arm blood pressure (BP) device (due to cognitive, psychological, physical or other problems), or Patient is already at goal, or Should not participate in the study for any other reason
- Non-compliance with medical follow-up (frequent "no shows")
- Planned coronary revascularization in the next 6 months
- Myocardial infarction, stroke, coronary revascularization, cardiac or aortic surgery in the last 3 months
Data sourced from ClinicalTrials.gov (NCT02988193). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.